Biotech

glue scissors art supplies

Biotech

Novartis sticks 2nd deal with Orionis, this one worth up to $1.4B

Novartis stuck a second deal with Orionis, this time handing $40 million to the molecular glue biotech to work on “challenging therapeutic targets.”

James Waldron Jun 10, 2026 8:21am

calendar

Parabilis’ upsized $670M IPO breaks new for record for biotechs

Jun 10, 2026 4:36am

How AI is reshaping biopharma decision-making

How AI is reshaping biopharma decision-making

Brought to you by Clarivate

Sanofi

Sanofi halts phase 3 autoimmune trial early over lackluster data

Jun 10, 2026 4:25am

Managing complexity across biopharma modalities

Managing complexity across biopharma modalities

Brought to you by SK Pharmteco

Magnifying glass focusing on number 2026 with target icon on yellow background

Despite headwinds, biotech industry charges forward behind M&A

Jun 9, 2026 12:41pm